Positive outcome in a patient with coronavirus disease 2019 and common variable immunodeficiency after intravenous immunoglobulin
- PMID: 32505720
- PMCID: PMC7272161
- DOI: 10.1016/j.anai.2020.06.006
Positive outcome in a patient with coronavirus disease 2019 and common variable immunodeficiency after intravenous immunoglobulin
Similar articles
-
The clinical observation of a patient with common variable immunodeficiency diagnosed as having coronavirus disease 2019.Ann Allergy Asthma Immunol. 2020 Jul;125(1):112-114. doi: 10.1016/j.anai.2020.04.033. Epub 2020 May 5. Ann Allergy Asthma Immunol. 2020. PMID: 32387167 Free PMC article. No abstract available.
-
Ten things we learned about COVID-19.Intensive Care Med. 2020 Aug;46(8):1590-1593. doi: 10.1007/s00134-020-06140-0. Epub 2020 Jun 5. Intensive Care Med. 2020. PMID: 32504103 Free PMC article. No abstract available.
-
Clinical findings in a patient with haemophilia A affected by COVID-19.Haemophilia. 2020 Jul;26(4):e214-e216. doi: 10.1111/hae.14000. Epub 2020 Apr 13. Haemophilia. 2020. PMID: 32239590 Free PMC article. No abstract available.
-
Cell-Free Therapies: Novel Approaches for COVID-19.Front Immunol. 2020 Sep 18;11:583017. doi: 10.3389/fimmu.2020.583017. eCollection 2020. Front Immunol. 2020. PMID: 33072130 Free PMC article. Review. No abstract available.
-
Understanding the Singapore COVID-19 Experience: Implications for Hospital Medicine.J Hosp Med. 2020 May;15(5):281-283. doi: 10.12788/jhm.3436. Epub 2020 Apr 16. J Hosp Med. 2020. PMID: 32379029 Review. No abstract available.
Cited by
-
A male infant with COVID-19 in the context of ARPC1B deficiency.Pediatr Allergy Immunol. 2021 Jan;32(1):199-201. doi: 10.1111/pai.13322. Epub 2020 Sep 2. Pediatr Allergy Immunol. 2021. PMID: 32683750 Free PMC article. No abstract available.
-
B Cell Response Induced by SARS-CoV-2 Infection Is Boosted by the BNT162b2 Vaccine in Primary Antibody Deficiencies.Cells. 2021 Oct 27;10(11):2915. doi: 10.3390/cells10112915. Cells. 2021. PMID: 34831138 Free PMC article.
-
Clinical and immunological outcomes of SARS-CoV-2 infection in patients with inborn errors of immunity receiving different brands and doses of COVID-19 vaccines.Tuberk Toraks. 2023 Sep;71(3):236-249. doi: 10.5578/tt.20239705. Tuberk Toraks. 2023. PMID: 37740627 Free PMC article.
-
Cytokine release syndrome in COVID-19: a major mechanism of morbidity and mortality.Int Rev Immunol. 2022;41(2):217-230. doi: 10.1080/08830185.2021.1884248. Epub 2021 Feb 22. Int Rev Immunol. 2022. PMID: 33616462 Free PMC article.
-
COVID-19 infection in CVID patients: What we know so far.Immun Inflamm Dis. 2021 Sep;9(3):632-634. doi: 10.1002/iid3.450. Epub 2021 May 12. Immun Inflamm Dis. 2021. PMID: 33979068 Free PMC article.
References
-
- Ferro F., Elefante E., Baldini C. COVID-19: the new challenge for rheumatologists. Clin Exp Rheumatol. 2020;38(2):175–180. - PubMed
-
- Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention [e-pub ahead of print]. JAMA. https://doi.org/10.1001/jama.2020.2648 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources